Phosphoinositide 3-kinases and their role in inflammation: potential clinical targets in atherosclerosis?
about
Ginkgolide B reduces LOX-1 expression by inhibiting Akt phosphorylation and increasing Sirt1 expression in oxidized LDL-stimulated human umbilical vein endothelial cellsPhosphorylation of CSF-1R Y721 mediates its association with PI3K to regulate macrophage motility and enhancement of tumor cell invasion.Enhanced macrophage tribbles-1 expression in murine experimental atherosclerosisBST-2/tetherin is overexpressed in mammary gland and tumor tissues in MMTV-induced mammary cancer.Targeting PI3Kγ activity decreases vascular trauma-induced intimal hyperplasia through modulation of the Th1 response.The inhibitory effect of PIK-75 on inflammatory mediator response induced by hydrogen peroxide in feline esophageal epithelial cellsDevelopment and application of PI3K assays for novel drug discovery.Wortmannin, PI3K/Akt signaling pathway inhibitor, attenuates thyroid injury associated with severe acute pancreatitis in rats.Ropinirole alters gene expression profiles in SH-SY5Y cells: a whole genome microarray study.Role of phosphoinositide 3-kinase in the pathogenesis of acute pancreatitis.Dual AAV/IL-10 Plus STAT3 Anti-Inflammatory Gene Delivery Lowers Atherosclerosis in LDLR KO Mice, but without Increased Benefit.Phylogenomics of phosphoinositide lipid kinases: perspectives on the evolution of second messenger signaling and drug discoveryMatrix ageing and vascular impacts: focus on elastin fragmentation.A Lys49 phospholipase A2, isolated from Bothrops asper snake venom, induces lipid droplet formation in macrophages which depends on distinct signaling pathways and the C-terminal region.Elastin-derived peptides potentiate atherosclerosis through the immune Neu1-PI3Kγ pathway.
P2860
Q28533547-17A0E8C6-5067-43CB-BC99-AE2CEB69AA07Q28585559-156B6175-F591-4D41-8B1B-80788A48430CQ33570357-CD4B6E50-DADA-46A1-B51C-0691B6461F44Q33631179-79D302AE-4B56-4FC6-9F84-EDDEF6DEB202Q34089207-990AC0D0-35DC-498A-945B-D7CF94AA7474Q34222253-7AC0461A-A2CF-4946-940D-F8F0069B04FDQ35535379-572B1A69-4B7F-4AC5-9FD9-9815F3F2CD4EQ36464272-DB22E1C0-2D2A-4437-B4F1-A9DF805493DDQ36497193-D684BBEA-766D-48E5-A1F8-415219D3CF37Q38266869-13C6B00F-051F-4F9C-AA78-E19C8B4A8426Q38369335-83722EBA-E744-4D13-8483-3DEB75C92100Q38503780-A945B009-17C3-46E7-989C-377052566CE7Q38786598-BB5D5EA2-6206-4693-A6BA-954A0F8EEBD4Q41480789-C47C8C6C-962B-48BA-B068-01AB5AA4A5D7Q54389170-65D7F75D-B982-4794-BF86-82423A9B55A0
P2860
Phosphoinositide 3-kinases and their role in inflammation: potential clinical targets in atherosclerosis?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Phosphoinositide 3-kinases and ...... al targets in atherosclerosis?
@en
Phosphoinositide 3-kinases and ...... al targets in atherosclerosis?
@nl
type
label
Phosphoinositide 3-kinases and ...... al targets in atherosclerosis?
@en
Phosphoinositide 3-kinases and ...... al targets in atherosclerosis?
@nl
prefLabel
Phosphoinositide 3-kinases and ...... al targets in atherosclerosis?
@en
Phosphoinositide 3-kinases and ...... al targets in atherosclerosis?
@nl
P2093
P2860
P356
P1433
P1476
Phosphoinositide 3-kinases and ...... al targets in atherosclerosis?
@en
P2093
Anne Fougerat
Fabienne Briand-Mesange
Monique Breton-Douillon
Nicole Malet
Stéphanie Gayral
P2860
P304
P356
10.1042/CS20080549
P407
P577
2009-05-01T00:00:00Z